Back to search
FDAFDA · Food and drugs·Recall number D-0598-2016

Hydromorphone HCl 1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 1 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc.

Published February 3, 2016 · Recall initiated: August 19, 2015

Summary

FDA records drug Class II recall D-0598-2016, published February 3, 2016 and initiated August 19, 2015. Recalling firm: Pharmakon Pharmaceuticals; Status: Terminated; Reported quantity: 8000; Lot: All lots with expiration dates up to 11/17/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Stability data does not support expiry.

What to do

Voluntary: Firm initiated · Telephone

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pharmakon Pharmaceuticals
Distributor
Nationwide
Lot
All lots with expiration dates up to 11/17/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydromorphone HCl 1 mg/mL in 0.9% Sodium Chloride, injectable packed in syringes, Total dosage 1 mg/ 1mL, Rx only, PHARMAKON Pharmaceuticals, Inc. recalled?

Yes. FDA published recall D-0598-2016 on February 3, 2016. Reported hazard: Stability data does not support expiry.

What should I do if I have this product?

Voluntary: Firm initiated · Telephone